Study of blood thinners in artery disease
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at how blood-thinning medications (like aspirin and clopidogrel) work in people with hardened arteries or peripheral artery disease (PAD). By understanding this, doctors hope to improve treatment and prevent heart attacks and strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed cardiovascular condition such as atherosclerosis (hardening of the arteries) or peripheral artery disease (PAD, reduced blood flow to the legs).
- You have not taken any blood thinner (like aspirin, clopidogrel, or warfarin) in the past two weeks (unless you are in the peripheral artery disease group).
- You have not taken a statin (cholesterol-lowering medication) in the past two weeks (unless you are in the peripheral artery disease group).
- You do not have diabetes, severe liver disease, anemia, or an active stomach ulcer.
- You are willing to give a blood sample and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
This trial compares two common “blood thinner” combinations to prevent problems after a PCI procedure for complex blocked heart arteries. It may help your care team find which combination works better for people with higher-risk artery patterns.
This study looks at whether giving certain blood-thinning medicines after a leg artery procedure helps prevent serious problems like heart attacks or strokes. It compares different treatment plans to see which is safer and more effective.
This study follows people with known coronary artery disease to understand how long-term “blood thinner” treatments are used and how they affect health over time. You may be asked to share medical information and come in for follow-up to help researchers compare outcomes.
This trial tests whether clopidogrel (a blood-thinning medicine) can prevent future heart attacks or strokes in people who have early, “subclinical” plaque in their heart arteries. You may be considered if scans show plaque but not major artery blockage that needs a procedure.
This study compares two ways to lower the chances of another heart attack: taking the standard medicine (clopidogrel) versus taking a combination of aspirin and a lower dose of a blood thinner (rivaroxaban). If you join, you'll be assigned to one of these options to see which works better for people like you.
Hear when a new Peripheral Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.